Fabino Enterprises
Fabino Enterprises (FABINO) share price was ₹20.31 at the 27 Apr 2026 close; sector Healthcare. In the Mar 2026 quarter, revenue rose 3.1% year on year to ₹14.21 Cr and net profit was −₹0.37 Cr, against ₹0.03 Cr a year earlier (compared with Mar 2025). Promoters held 56.96% of Fabino Enterprises in Sep 2026, up 0.14 percentage points from Mar 2026.
Key Fundamentals
SMEPharmaceuticals & BiotechnologyHealthcarePrice-based figures · TTM
Peer Comparison
Healthcare › Pharmaceuticals
| ₹1,765.80 | 35.03 | 4,23,675 Cr | 5.07 | 0.91% | 13.79% | 17.94% | 61,848 Cr | 12,117 Cr | |
| ₹9,653.00 | 87.61 | 2,56,257 Cr | 15.29 | 0.32% | 15.32% | 18.96% | 11,682 Cr | 2,925 Cr | |
| ₹4,606.60 | 72.32 | 1,75,220 Cr | 9.54 | 0.82% | 12.16% | 9.06% | 17,058 Cr | 2,156 Cr | |
| ₹2,186.60 | 108.03 | 1,18,145 Cr | 22.29 | 0.09% | 16.38% | 19.67% | 7,323 Cr | 1,090 Cr | |
| ₹1,181.30 | 26.29 | 1,17,835 Cr | 4.35 | 0.09% | 16.99% | 19.24% | 28,515 Cr | 4,593 Cr | |
| ₹1,338.80 | 34.67 | 1,11,747 Cr | 2.88 | 0.61% | 10.87% | 13.94% | 34,247 Cr | 3,184 Cr | |
| ₹1,364.70 | 32.70 | 1,10,248 Cr | 3.11 | 0.96% | 11.21% | 14.88% | 28,589 Cr | 3,356 Cr | |
| Fabino Enterprises (this company) | — | — | 4 Cr | 1.17 | 0.00% | -15.32% | -11.49% | 2 Cr | -0 Cr |
| Median 8 companies | ₹1,765.80 | 35.03 | 1,17,990 Cr | 4.71 | 0.47% | 12.98% | 16.41% | 22,787 Cr | 3,055 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100. How it works →
No Tapetide Score has been computed for this stock yet.
Key Insights
Strengths
1- Stock is trading at 1.17 times its book value
Weaknesses
3- Company has low interest coverage ratio.
- Company has a low return on equity of -3.76% over last 3 years.
- Company has high debtors of 288 days.
Technical Indicators
Oscillators
Bearish
Overall
Bearish
Moving Averages
Neutral
Growth Rate
change over 1 year
change over 1 year
change over 1 year
change over 1 year Operating margin -12.32% · Mar 2026
Quarterly Results
| Particulars | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 2.32 | 12.86 | 8.22 | 4.25 | 13.78 | 6.63 | 14.21 |
| Expenses | 2.3 | 12.74 | 8.23 | 4.22 | 13.7 | 6.95 | 15.96 |
| Operating Profit | 0.02 | 0.12 | -0.01 | 0.03 | 0.08 | -0.32 | -1.75 |
| OPM % | 0.86% | 0.93% | -0.12% | 0.71% | 0.58% | -4.83% | -12.32% |
| Other Income | 0 | 0.01 | 0 | 0.11 | 0.18 | 0.28 | 1.29 |
| Interest | 0 | 0 | 0.03 | 0.06 | 0.07 | 0.09 | 0.04 |
| Depreciation | 0.02 | 0.01 | 0.03 | 0.04 | 0.04 | 0.06 | 0.05 |
| PBT | 0 | 0.12 | -0.07 | 0.04 | 0.15 | -0.19 | -0.55 |
| Tax % | — | 25% | -28.57% | 25% | 80% | 0% | -32.73% |
| Net Profit | 0 | 0.09 | -0.05 | 0.03 | 0.03 | -0.19 | -0.37 |
| EPS (₹) | 0 | 0.43 | -0.24 | 0.14 | 0.14 | -0.9 | -1.76 |
Profit & Loss
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 3.36 | 21.01 | 17.98 | 20.83 |
| Expenses | 3.33 | 20.89 | 17.87 | 22.88 |
| Operating Profit | 0.03 | 0.12 | 0.11 | -2.05 |
| OPM % | 0.89% | 0.57% | 0.61% | -9.84% |
| Other Income | 0.02 | 0.01 | 0.29 | 1.56 |
| Interest | 0.01 | 0.04 | 0.13 | 0.14 |
| Depreciation | 0.03 | 0.04 | 0.08 | 0.11 |
| PBT | 0.01 | 0.05 | 0.19 | -0.74 |
| Tax % | 0% | 20% | 68.42% | -24.32% |
| Net Profit | 0.01 | 0.04 | 0.06 | -0.56 |
| EPS (₹) | 0.05 | 0.19 | 0.29 | -2.67 |
| Div. Payout % | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 2.1 | 2.1 | 2.1 | 2.1 |
| Reserves | 2.01 | 2.04 | 2.1 | 1.55 |
| Borrowings | 0.41 | 1.27 | 1.79 | 1.62 |
| Other Liabilities | 0.5 | 9.95 | 11.67 | 16.87 |
| Total Liabilities | 5.02 | 15.36 | 17.66 | 22.14 |
| Fixed Assets | 0.15 | 0.34 | 0.55 | 0.37 |
| CWIP | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 |
| Other Assets | 4.87 | 15.02 | 17.11 | 21.77 |
| Total Assets | 5.02 | 15.36 | 17.66 | 22.14 |
Cash Flow
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Operating | -0.68 | -0.77 | 0.12 | 0.19 |
| Investing | -0.01 | -0.28 | -0.29 | 0.07 |
| Financing | 0.34 | 0.86 | 0.35 | -0.3 |
| Net Cash Flow | -0.35 | -0.18 | 0.18 | -0.05 |
| Free Cash Flow | -0.69 | -1.01 | -0.17 | 0.26 |
| CFO/EBITDA | -2,233 | -633 | 227 | -9 |
Ratios
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Debtor Days | 275 | 219 | 288 | 288 |
| Inventory Days | 147 | 24.21 | 26.56 | 19.14 |
| Days Payable | 45.78 | 179 | 253 | 297 |
| Cash Conversion Cycle | 376 | 63.97 | 61.44 | 10.12 |
| Working Capital Days | 444 | 86.34 | 104 | 78.33 |
| ROCE % | — | 1.81% | 5.61% | -10.66% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Fabino Enterprises insights
55 extracted metrics + investor summaries across FY22–FY26.
Documents
Frequently Asked Questions about Fabino Enterprises
What does Fabino Enterprises Ltd do?
Where is Fabino Enterprises Ltd (FABINO) listed?
Which sector does Fabino Enterprises Ltd belong to?
What is the Return on Equity (ROE) of Fabino Enterprises Ltd?
Company Information
Incorporated in 2011, Fabino Enterprises manufactures, markets, trades, and does packing of pharmaceutical and other wellness focused consumer products[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/543444.md for Fabino Enterprises Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.